Novel Strategy to Quantitate Delayed Aging by Caloric Restriction
Novel Strategy to Quantitate Delayed Aging by Caloric Restriction
批准号:
10594352
负责人:
ALEXEY V TERSKIKH
金额:
$41.09万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-02-15 至 2024-01-31
关键词:
ATAC-seqAgeAgingAlgorithmsAnimalsAttentionBayesian MethodBedsBiologicalCaloric RestrictionChromatinClassificationCommunitiesComputational algorithmDataData AnalysesData ScientistData SetDimensionsEcosystemEnsureFeedbackGene ExpressionGeometryImageIndividualLabelMachine LearningMapsMeasurementMemoryMethodsModalityModelingMultiomic DataMusPeer ReviewPhenotypePlant LeavesProgramming LanguagesPublicationsPythonsQuality ControlReadinessResearchResearch PersonnelRunningStructureTestingTextureTranscriptVariantVisualizationWorkXCL1 geneanalysis pipelineautoencoderbasecellular imagingcloud platformcomputational pipelinesdata modelingdata streamsdata structuredeep learning modeldesigndietary controldietary restrictiondigital repositoriesexperimental studyfile formatgenome sequencingimprovedmetabolomicsmicroscopic imagingmultidimensional datamultimodal datamultimodalityneural networknovel strategiestooltranscriptome sequencingwhole genome
中文摘要
项目总结
父母应用程序建议整合来自对照的单细胞成像、ATAC-SEQ和RNA-SEQ数据
饮食小鼠和卡路里限制(CR)饮食小鼠。这些实验将提供大量的
不仅适用于AI/ML应用的多维和多模式数据,实际上还需要AI/ML
理解海量数据集的方法。然而,这些数据集来自3种不同类型的
测量(显微成像、染色质可获得性和基因表达)
(成像和测序)是非常不同的。目前,所有三个数据流都是以传统方式处理的
主要使用非常大的Excel文件;这种数据结构/格式不适合AI/ML集成。因此,
需要单独的方法来清理、过滤和质量控制(QC)成像数据,ATAC-SEQ和
RNA序列数据。下一个关键步骤是以类似的格式组织这些不同的数据集,以简化存储
以及使用AI/ML算法处理和启用下游集成和分析。为了满足这些要求
挑战,我们将实施AnnData格式,该格式提供了广泛的计算效率
功能包括稀疏数据支持、Scanpy和一个PyTorch接口。以确保
Ann来自非常不同的模式(成像、ATAC-SEQ、RNA-SEQ)的数据可以一起分析,我们将进行测试
运行已经开发的计算算法,最适合高效地吸收和组合多个
组学数据,以确定推动衰老的关键因素。我们将结合来自IMAGING、ATAC-SEQ、
和rna-seq使用贝叶斯方法集成多组学数据和双曲线嵌入与原理
选择最适合的曲率和尺寸的标准。为了进一步测试嵌入数据的实用性,我们
将使用VAE和GAN测试CNN在嵌入式数据集合上的运行,以确保终端就绪和
从不同的AI/ML应用程序获得初步反馈。最后,我们将建立一个电子储存库,用于
将Python脚本和AnnData对象和结构直接传播到广泛的研究中
社区。
英文摘要
PROJECT SUMMARY
The parental application proposed to integrate single cell imaging, ATAC-seq, and RNA-seq data from control
diet mice and caloric restriction (CR) diet mice. These experiments will provide a large amount of
multidimensional and multimodal data that not just suited for AI/ML applications, but in fact, require AI/ML
approaches to make sense of the vast datasets. However, these datasets are coming from 3 different type of
measurements (microscopic imaging, chromatin accessibility, and gene expression) of which 2 modalities
(imaging and sequencing) are very different. At present all three data streams are handled in conventional ways
primarily using very large Excel files; this data structure / format is not suitable for AI/ML integration. Hence the
need for individual approaches to cleaning, filtering, and quality control (QC) of imaging data, ATAC-seq and
RNA-seq data. Next critical step is to structure these diverse datasets in a similar format that streamlines storage
and handling and enabling downstream integration and analyses using AI/ML algorithms. To meet these
challenges, we will implement the AnnData format, which offers a broad range of computationally efficient
features including, among others, sparse data support, Scanpy, and a PyTorch interface. To ensure that
AnnData from very different modalities (imaging, ATAC-seq, RNA-seq) could be analyzed together, we will test
run already developed computational algorithms that best suited to efficiently assimilate and combine multi-
omics data to identify key factors that drive aging. We will combine AnnData objects from imaging, ATAC-seq,
and RNA-seq using Bayesian methods for integrating multi-omics data and hyperbolic embedding with principled
criteria for choosing the best-fitting curvature and dimension. To further test the utility of the embedded data we
will test run CNN with VAEs and GAN on the ensemble of embedded data to ensure the endpoint readiness and
to obtain initial feedback from different AI/ML applications. Finally, we will establish an electronic repository for
python scripts and AnnData objects and structures for a straightforward dissemination to the broad research
community.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Testing the utility of miBioAge as a personalized aging biomarker
-
批准号:10728233
-
项目类别:
-
资助金额:$56.98万
-
财政年份:2023
-
负责人:ALEXEY V TERSKIKH
-
依托单位:
Novel Strategy to Quantitate Delayed Aging by Caloric Restriction
-
批准号:10355362
-
项目类别:
-
资助金额:$29.87万
-
财政年份:2022
-
负责人:ALEXEY V TERSKIKH
-
依托单位:
Novel Strategy to Quantitate Delayed Aging by Caloric Restriction
-
批准号:10570275
-
项目类别:
-
资助金额:$25.02万
-
财政年份:2022
-
负责人:ALEXEY V TERSKIKH
-
依托单位:
Role of Epigenetically Active Environmental Compounds in Neurodevelopmental Disorders
-
批准号:10219009
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2021
-
负责人:ALEXEY V TERSKIKH
-
依托单位:
Role of Epigenetically Active Environmental Compounds in Neurodevelopmental Disorders
-
批准号:10395566
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2021
-
负责人:ALEXEY V TERSKIKH
-
依托单位:
Phenotypic Screening for Longevity Interventions Using Single-cell Epigenetic Signatures
-
批准号:10225468
-
项目类别:
-
资助金额:$24.38万
-
财政年份:2020
-
负责人:ALEXEY V TERSKIKH
-
依托单位:
Role of Epigenetically Active Environmental Compounds in Neurodevelopmental Disorders
-
批准号:10271253
-
项目类别:
-
资助金额:$24.38万
-
财政年份:2020
-
负责人:ALEXEY V TERSKIKH
-
依托单位:
Role of Epigenetically Active Environmental Compounds in Neurodevelopmental Disorders
-
批准号:9979666
-
项目类别:
-
资助金额:$29.25万
-
财政年份:2020
-
负责人:ALEXEY V TERSKIKH
-
依托单位:
Phenotypic Screening for Longevity Interventions Using Single-cell Epigenetic Signatures
-
批准号:10043841
-
项目类别:
-
资助金额:$29.25万
-
财政年份:2020
-
负责人:ALEXEY V TERSKIKH
-
依托单位:
Role of MELK in glioblastomas
-
批准号:7794961
-
项目类别:
-
资助金额:$43.09万
-
财政年份:2010
-
负责人:ALEXEY V TERSKIKH
-
依托单位:
Role of MELK in glioblastomas
-
批准号:8113635
-
项目类别:
-
资助金额:$4.78万
-
财政年份:2010
-
负责人:ALEXEY V TERSKIKH
-
依托单位:
Role of MELK in glioblastomas
-
批准号:8022951
-
项目类别:
-
资助金额:$39.99万
-
财政年份:2010
-
负责人:ALEXEY V TERSKIKH
-
依托单位:
Role of MELK in glioblastomas
-
批准号:8450849
-
项目类别:
-
资助金额:$39.32万
-
财政年份:2010
-
负责人:ALEXEY V TERSKIKH
-
依托单位:
Role of MELK in glioblastomas
-
批准号:8214618
-
项目类别:
-
资助金额:$39.99万
-
财政年份:2010
-
负责人:ALEXEY V TERSKIKH
-
依托单位:
MELK as Functional Marker for Mammary Tumors
-
批准号:7387571
-
项目类别:
-
资助金额:$25.79万
-
财政年份:2008
-
负责人:ALEXEY V TERSKIKH
-
依托单位:
MELK as Functional Marker for Mammary Tumors
-
批准号:7619102
-
项目类别:
-
资助金额:$21.49万
-
财政年份:2008
-
负责人:ALEXEY V TERSKIKH
-
依托单位:
Protein Acetylation Signature of ES Cell Differentiation
-
批准号:7031897
-
项目类别:
-
资助金额:$25.79万
-
财政年份:2006
-
负责人:ALEXEY V TERSKIKH
-
依托单位:
Protein Acetylation Signature of ES Cell Differentiation
-
批准号:7244065
-
项目类别:
-
资助金额:$20.86万
-
财政年份:2006
-
负责人:ALEXEY V TERSKIKH
-
依托单位:
Separation of Stem Cells From Differentiated Cells
-
批准号:6829374
-
项目类别:
-
资助金额:$17.67万
-
财政年份:2004
-
负责人:ALEXEY V TERSKIKH
-
依托单位:
Separation of Stem Cells From Differentiated Cells
-
批准号:6914358
-
项目类别:
-
资助金额:$17.67万
-
财政年份:2004
-
负责人:ALEXEY V TERSKIKH
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: